TRPV2: A Cancer Biomarker and Potential Therapeutic Target

The Transient Receptor Potential Vanilloid type-2 (TRPV2) channel exhibits oncogenicity in different types of cancers. TRPV2 is implicated in signaling pathways that mediate cell survival, proliferation, and metastasis. In leukemia and bladder cancer, the oncogenic activity of TRPV2 was linked to al...

Descripción completa

Detalles Bibliográficos
Autores principales: Siveen, Kodappully S., Nizamuddin, Parveen B., Uddin, Shahab, Al-Thani, Mohamed, Frenneaux, Michael Paul, Janahi, Ibrahim A., Steinhoff, Martin, Azizi, Fouad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746447/
https://www.ncbi.nlm.nih.gov/pubmed/33376561
http://dx.doi.org/10.1155/2020/8892312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746447/
https://www.ncbi.nlm.nih.gov/pubmed/33376561
http://dx.doi.org/10.1155/2020/8892312

Ejemplares similares